Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Cardiovascular Imaging
Should there be age cut-off considerations when ordering TTEs with bubble routinely as part of stroke work-up?
If so, what age group would be less likely to benefit from bubble studies?
Related Questions
What is the role of MRI in assessing the risk of embolism in patients with persistent left ventricular thrombus following myocardial infarction?
What techniques do you find most helpful to optimize image acquisition for cardiac POCUS in patients with poor acoustic windows?
What is your systolic blood pressure target for patients over 80 with frailty and multiple comorbidities?
What should the LDL target be in patients with prediabetes and high lipoprotein (a) with family history of coronary artery disease?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?
What class(es) of antihypertensives should be considered next for refractory hypertension in a patient compliant with high doses of Entresto, chlorthalidone, amlodipine, clonidine, and spironolactone if they previously did not have any improvement on beta blocker or hydralazine and work-up for secondary causes were unremarkable?
Would you favor CT AV calcium score or dobutamine stress echo for a patient with symptomatic AS and aortic valve with normal SV/SV index, Vmax 3.4m/s, AVA < 1.0cm2 and mean gradient < 40mmHg?
How should we approach the recommendation of intermittent fasting for weight loss in patients with pre-existing cardiovascular conditions, given the observed association of increased CV mortality with eating durations of less than 8 hrs?
Do you recommend starting a statin in patients above 75 years old with diabetes but no known ASCVD?
Where does dronedarone fall in your list of antiarrhythmics drugs to use in terms of efficacy and patient selection in contemporary management of atrial fibrillation?